Position in AZN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,533,323
New position
Shares Held
13,360
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#483
of 1,462 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATURAL INVESTMENTS, LLC holds $27,100,287 across 13 Drug Manufacturers - General names. AZN ranks #3 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
33,331 | $8,387,412 | |
| 2 | LLY |
ELI LILLY & Co
|
5,609 | $6,727,603 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
13,360 | $2,533,323 | |
| 4 | JNJ |
Johnson & Johnson
|
9,613 | $2,441,413 | |
| 5 | MRK |
Merck & Co., Inc.
|
15,454 | $1,985,839 | |
| 6 | AMGN |
Amgen Inc
|
3,879 | $1,404,663 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,354 | $929,104 | |
| 8 | NVS |
Novartis AG
|
5,116 | $801,779 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,533,323 | 13,360 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||